Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does TOZINAMERAN Cause Multiple sclerosis relapse? 61 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 61 reports of Multiple sclerosis relapse have been filed in association with TOZINAMERAN. This represents 0.9% of all adverse event reports for TOZINAMERAN.

61
Reports of Multiple sclerosis relapse with TOZINAMERAN
0.9%
of all TOZINAMERAN reports
0
Deaths
39
Hospitalizations

How Dangerous Is Multiple sclerosis relapse From TOZINAMERAN?

Of the 61 reports, 39 (63.9%) required hospitalization, and 1 (1.6%) were considered life-threatening.

Is Multiple sclerosis relapse Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for TOZINAMERAN. However, 61 reports have been filed with the FAERS database.

What Other Side Effects Does TOZINAMERAN Cause?

Fatigue (1,197) Headache (904) Covid-19 (896) Pain in extremity (675) Pyrexia (665) Pain (633) Drug ineffective (547) Nausea (473) Arthralgia (464) Off label use (446)

What Other Drugs Cause Multiple sclerosis relapse?

DIMETHYL (6,852) FINGOLIMOD (6,728) NATALIZUMAB (6,478) INTERFERON BETA-1A (5,931) TERIFLUNOMIDE (4,745) GLATIRAMER (3,695) DALFAMPRIDINE (3,322) OCRELIZUMAB (2,326) OFATUMUMAB (1,525) INTERFERON BETA-1B (1,229)

Which TOZINAMERAN Alternatives Have Lower Multiple sclerosis relapse Risk?

TOZINAMERAN vs TRABECTEDIN TOZINAMERAN vs TRACLEER TOZINAMERAN vs TRADJENTA TOZINAMERAN vs TRALOKINUMAB-LDRM TOZINAMERAN vs TRAMADOL

Related Pages

TOZINAMERAN Full Profile All Multiple sclerosis relapse Reports All Drugs Causing Multiple sclerosis relapse TOZINAMERAN Demographics